
Latest stock market news, company updates, and price movements. Stay updated with market trends, earnings insights, and investment analysis.
A CEEW-NRDC India study says meeting India’s 500 GW non-fossil target by 2030 could create over 44 lakh FTE jobs, led by rooftop solar.
Aurobindo Pharma and Zydus Cadila disclosed USFDA decisions on multiple generic medicines, including Rivaroxaban 2.5 mg with a Q1FY26 launch plan and Tofacitinib XR exclusivity.
ABB won a Cochin Shipyard contract to supply power, propulsion and automation systems for two battery-electric harbour tugs for JNPA under India’s GTTP, due 2027.
India is weighing selective spending cuts as oil-led subsidy costs rise, while keeping infrastructure capex intact and aiming for a 4.3% of GDP fiscal deficit in FY27.
Aurobindo Pharma shares rose up to 4.2% after its unit won USFDA approval for multiple-strength Dasatinib tablets, targeted for a Q1 FY26 launch.
A 4% drop in crude is lifting risk appetite, but FII outflows, rupee concerns and delayed fuel price pass-through still keep Indian equities cautious.
PhysicsWallah is exiting direct student financing and will route education loans via regulated NBFC partners, a shift that follows a ₹120 crore infusion into FinZ Finance.
PhysicsWallah shares rallied up to 18% on June 4 after it dropped a ₹120 crore in-house lending plan and shifted student financing to regulated partner NBFCs.
Meesho stock extends its post-listing sell-off to eight sessions as June 9 lock-in expiry and a senior exit add pressure, despite FY26 loss narrowing.
Congress questioned LIC’s 10.8% holding in Rajesh Exports after SEBI alleged revenue misrepresentation of about ₹1,515,000 crore and imposed interim restrictions on the promoter-CEO.
PhysicsWallah shares surged up to 18% after the edtech firm scrapped direct student lending plans and shifted to a platform model with regulated NBFC partners.
Rajesh Exports told exchanges Sebi’s interim order reflects a communication gap, denied revenue overstatement, and said it is submitting documents after allegations of ₹1,515,000 crore misreporting.
Asian equities and US tech futures slipped after Broadcom’s outlook disappointed, while renewed US-Iran hostilities and shifting oil prices kept risk sentiment cautious.
Hyundai Motor India is ramping up local EV production with the Creta EV, targeting 20% electric passenger vehicle share, capacity expansion, and a broader five-model EV roadmap by 2030.
Broadcom shares sank after a slight quarterly revenue miss and a third-quarter AI chip revenue outlook below estimates, despite higher 2027 shipment forecasts and a $100 billion target.
Tata Motors Passenger Vehicles plans ₹33,000-35,000 crore investment through FY30 to target 18-20% market share, expand EVs overseas, and lift EV mix to 30% by 2030.